Cost-benefit analysis of antimicrobial stewardship program in a cancer setting in Qatar
<h3>Background</h3><p dir="ltr">It is estimated that physicians prescribe antibiotics inappropriately in 50% of cases.1,2 We aimed to compare the economic advantage of mature antimicrobial stewardship program (ASP) versus premature ASP use in hematology and oncology setti...
محفوظ في:
| المؤلف الرئيسي: | Dina Abushanab (10696501) (author) |
|---|---|
| مؤلفون آخرون: | Diala Alhaj Moustafa (18472430) (author), Bhagyasree Adampally Sankar (18472431) (author), Ziad Nasr (18472432) (author), Moza Al Hail (2511859) (author), Anas Hamad (9545771) (author), Palli Valappila Abdul Rouf (18472377) (author), Wessam Elkassem (18472434) (author), Binny Thomas (5801969) (author), Daoud Al-Badriyeh (832403) (author) |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Cost-Benefit Analysis of Antimicrobial Stewardship Program in the Adult General Medicine Setting in Qatar
حسب: Dina Abushanab (10696501)
منشور في: (2024) -
The cost-benefit associated with the maturity of the Antimicrobial Stewardship Program versus prematurity in Heart Hospital of Hamad Medical Corporation in Qatar
حسب: Dina Abushanab (10696501)
منشور في: (2023) -
Cost-Benefit Analysis of Antimicrobial Stewardship Program in Women’s Health at Hamad Medical Corporation in Qatar
حسب: Dina Abushanab (10696501)
منشور في: (2023) -
Cost-Benefit Analysis of Antimicrobial Stewardship Program Maturity in Adult Surgical Ward Settings: A Retrospective Study in Qatar
حسب: Nurhan Elshafey (18472387)
منشور في: (2024) -
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction in patients without diabetes in Qatar.
حسب: Dina Abushanab (10696501)
منشور في: (2024)